{"resourceType":"Parameters","parameter":[{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2013-0413-dose1-evaluation","status":"completed","patient":{"reference":"Patient/2013-0413"},"date":"2011-08-20T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2013-0413-dose1"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2013-0413-dose2-evaluation","status":"completed","patient":{"reference":"Patient/2013-0413"},"date":"2011-08-20T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2013-0413-dose2"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2013-0413-dose3-evaluation","status":"completed","patient":{"reference":"Patient/2013-0413"},"date":"2011-08-20T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2013-0413-dose3"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2013-0413"},"date":"2011-08-20T00:00:00.000","recommendation":[{"targetDisease":[{"coding":[{"system":"http//snomed.info/sct","code":"363354003","display":"Malignant tumour of cervix"},{"system":"http//snomed.info/sct","code":"266113007","display":"Genital warts"}]}],"forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"complete","display":"Complete"}]},"description":"Evaluation_Test_Type: Interval: At Absolute Minimum\nForecast_Test_Type: EvaluationNot recommended: series complete\nGeneral_Description: This test case describes when a child is administered a third dose of the HPV vaccine at 16 weeks - 1 day, after the first dose,  that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1).","series":"VaccineGroupName.hpv"}]}}]}